
Alembic Pharmaceuticals Ltd. Falls to 52-Week Low of Rs 645.1 as Sell-Off Deepens
2026-03-23 13:21:25A sharp decline of 4.72% today dragged Alembic Pharmaceuticals Ltd. to a fresh 52-week low of Rs 645.1, extending a downward trend that has seen the stock lose nearly 32% over the past year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 5.56% over the same period.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Hits 52-Week Low at Rs.659.55
2026-03-19 09:58:43Alembic Pharmaceuticals Ltd. has reached a new 52-week low, with its stock price falling to Rs.659.55 today. This marks a significant decline amid broader market fluctuations and ongoing sector pressures, reflecting a challenging period for the company within the Pharmaceuticals & Biotechnology industry.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.665.1
2026-03-17 15:46:16Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.665.1 today, marking a significant decline in its stock price amid a series of consecutive falls and underperformance relative to its sector and benchmark indices.
Read full news article
Alembic Pharmaceuticals Ltd. is Rated Sell
2026-03-17 10:10:02Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.670.35
2026-03-16 12:48:30Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.670.35, marking a significant decline amid a challenging market environment and subdued company performance. The stock has been on a downward trajectory over the past several sessions, reflecting broader sector pressures and company-specific factors.
Read full news article
Alembic Pharmaceuticals Ltd. is Rated Sell
2026-03-06 10:10:24Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.671
2026-03-02 12:20:03Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.671 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.725.3
2026-02-27 09:58:20Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.725.3 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors. This level represents a notable drop from its 52-week high of Rs.1107.8, reflecting ongoing challenges in both long-term and recent financial metrics.
Read full news article
Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.725.45
2026-02-26 15:39:49Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.725.45, marking a significant decline amid a broader market environment where the Sensex has shown mixed performance. The stock has underperformed its sector and key benchmarks, reflecting ongoing concerns about its recent financial results and valuation metrics.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20-Mar-2026 | Source : BSEIntimation of One on One Investor meet
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary
09-Mar-2026 | Source : BSEPlease find attached herewith the enclosed file.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Mar-2026 | Source : BSEIntimation of One on One Investor Meet
Corporate Actions
No Upcoming Board Meetings
Alembic Pharmaceuticals Ltd. has declared 550% dividend, ex-date: 29 Jul 25
No Splits history available
No Bonus history available
No Rights history available






